BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11109989)

  • 1. Sympathetic and parasympathetic interaction in vascular and secretory control of salivary glands in anaesthetised dogs.
    McCloskey MJ; Potter EK
    Auton Neurosci; 2000 Oct; 84(1-2):50-7. PubMed ID: 11109989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathetic and parasympathetic interaction in vascular and secretory control of the nasal mucosa in anaesthetized dogs.
    Revington M; Lacroix JS; Potter EK
    J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):823-31. PubMed ID: 9457655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilatation via Y2 prejunctional receptor.
    Lacroix JS; Ulman LG; Potter EK
    Br J Pharmacol; 1994 Oct; 113(2):479-84. PubMed ID: 7834199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of vagal vasodilatation by a selective neuropeptide Y Y2 receptor agonist in the bronchial circulation of anaesthetised dogs.
    Mahns DA; Lacroix JS; Potter EK
    J Auton Nerv Syst; 1998 Nov; 73(2-3):80-5. PubMed ID: 9862381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of sympathetic cholinergic vasodilatation by a selective NPY Y2 receptor agonist in the gracilis muscle of anaesthetised dogs.
    Mahns DA; Revington ML; Runcie MJ; McCloskey DI; Potter EK
    J Auton Nerv Syst; 1998 Jan; 68(1-2):14-20. PubMed ID: 9531441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y.
    Modin A; Pernow J; Lundberg JM
    Acta Physiol Scand; 1993 May; 148(1):1-11. PubMed ID: 8333291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NPY Y2 receptor agonist, N-acetyl [Leu28,Leu31]NPY24-36, reduces renal vasoconstrictor activity in anaesthetised dogs.
    Mahns DA; Kelly C; McCloskey DI; Potter EK
    J Auton Nerv Syst; 1999 Oct; 78(1):10-7. PubMed ID: 10589818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
    Malmström RE
    Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.
    Serone AP; Wright CE; Angus JA
    Br J Pharmacol; 1999 May; 127(1):99-108. PubMed ID: 10369461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle.
    Hoyo Y; McGrath JC; Vila E
    J Pharmacol Exp Ther; 2000 Jul; 294(1):38-44. PubMed ID: 10871293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa.
    Lacroix JS
    Acta Physiol Scand Suppl; 1989; 581():1-63. PubMed ID: 2568728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney.
    Oellerich WF; Malik KU
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1321-9. PubMed ID: 8371140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of NPY Y1 receptors in cardiovascular control in the conscious rabbit.
    Serone AP; Wright CE; Angus JA
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):315-21. PubMed ID: 10672867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
    Malmström RE; Balmér KC; Lundberg JM
    Br J Pharmacol; 1997 Jun; 121(3):595-603. PubMed ID: 9179405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vasodilator and secretory effects elicited by sympathetic nerve stimulation in cat submandibular gland.
    Izumi H; Karita K
    J Auton Nerv Syst; 1994 Jul; 48(2):143-51. PubMed ID: 8089396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neuropeptide Y and [Leu31,Pro34] neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat.
    Penner SB; Smyth DD; Glavin GB
    J Pharmacol Exp Ther; 1993 Jul; 266(1):339-43. PubMed ID: 8101219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
    Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
    Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.